Table 1 Patient characteristics between patients with and without renal recovery
Recovery (n = 100) | Non-recovery (n = 64) | p value | |
|---|---|---|---|
Age (years) | 60 (46, 72) | 56 (43, 66) | 0.259 |
Male gender | 65 (65.0) | 37 (57.8) | 0.410 |
Body mass index (kg/m2) | 22.9 (20.6, 25.4) | 23.9 (20.4, 27.0) | 0.162 |
APACHE II score | 13.0 (11, 17) | 17 (12, 22) | 0.014 |
Non-renal SOFA score | 4 (2, 7) | 6 (3, 10) | 0.026 |
Hemoglobin (g/L) | 90.0 (82, 102.5) | 91.0 (77, 109.0) | 0.499 |
Chronic comorbidities | |||
Diabetes | 18 (18.0) | 12 (18.8) | 1.000 |
Hypertension | 33 (33.0) | 24 (37.5) | 0.615 |
COPD | 5 (5.0) | 3 (4.7) | 1.000 |
Coronary artery disease | 16 (16.0) | 7 (10.9) | 0.490 |
CKD | 6 (6.0) | 7 (10.9) | 0.374 |
Chronic liver disease | 33 (33.0) | 25 (39.1) | 0.504 |
ACEI/ARB | 3 (3.0) | 6 (9.4) | 0.156 |
Reason for ICU admission | |||
Surgical | 62 (62.0) | 50 (78.1) | 0.030 |
Emergency | 24 (24.0) | 5 (7.8) | 0.008 |
Medical | 14 (14.0) | 9 (14.1) | 0.725 |
Mechanical ventilation | 84 (84.0) | 51 (79.7) | 0.532 |
PaO2/FiO2 | 302.5 (192.0, 420.0) | 288.3 (204.3, 413.7) | 0.562 |
Sepsis | 27 (27.0) | 16 (25.0) | 0.776 |
Vasopressors | 22 (22.0) | 10 (15.6) | 0.420 |
Nephrotoxic drugs use | 11 (11.0) | 8 (12.5) | 0.770 |
Baseline creatinine(µmol/L) | 65.0 (53.9, 76.3) | 65.4 (53.0, 76.0) | 0.915 |
Serum creatinine diagnosing AKI (µmol/L) | 113.0 (90.9, 144.0) | 135.6 (105.1, 205.1) | 0.001 |
eGFRa (mL/min/1.73 m2) | 58.6 ± 20.7 | 46.1 ± 22.9 | 0.001 |
UO 24 h after diagnosing AKI (mL/kg/h) | 0.42 (0.36, 0.47) | 0.27 (0.25, 0.36) | 0.002 |
AKI classification | |||
Stage 1 | 73 (73.0) | 18 (28.1) | < 0.001 |
Stage 2 | 22 (22.0) | 32 (50.0) | |
Stage 3 | 5 (5.0) | 14 (21.9) | |
Outcomes | |||
KRT in ICU | 9 (9) | 19 (30.6) | 0.001 |
Hospital mortality | 12 (12) | 13 (20.3) | 0.183 |
30-Day mortality | 11 (11) | 11 (17.2) | 0.348 |